《異動股》青啤(00168.HK)急彈20%重越20天線 A股漲停
內地新冠肺炎疫情受控,「封城」兩個月的武漢將會逐步解封,富瑞金融集團上周曾指出,受疫情大流行影響,中國市場上啤酒生產商將面臨短期衝擊,但若干公司利潤增長可能於2021年恢復正常,因為一旦危機結束,啤酒銷售就會復甦。
青啤(00168.HK)由低位急彈一舉重越10天及20天線(35.15元及38.33元),最高見38.6元,現造38.35元,急彈20%,成交急增至570萬股;其A股漲停報43.27元人民幣。
此外,華潤啤酒(00291.HK)重越10天、20天及50天線(33.85-37.5元),最高見35.6元,現造33.9元,彈5.6%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.